Company intelligence / Profile preview
GC Wellbeing
Seoul, South Koreagcwellbeing.co.kr ↗
- Ownership
- Private
- Employees
- ~101
- Development stage
- Other
01
Overview
GC Wellbeing develops and commercializes personalized nutritional injections, health functional foods, and placenta-derived pharmaceuticals. Its lead product, placenta injection, is marketed for liver function and chronic fatigue. Products are approved, commercialized, and sold both domestically and in certain international markets[1][4][5][9].
- Therapeutic areas
- NeurologyMetabolic DisordersOtherGastroenterology
- Modalities
- Small moleculeBiologicHealth supplementPersonalized nutritionPlacenta-derived product
- Industry
- Biotech
02
Drug pipeline
12 assets11 more assets in the full pipeline.
Beyond the preview
Go deeper on GC Wellbeing.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GC Wellbeing.